Studies of CD5-deficient mice indicate that the transmembrane glycoprotein CD5 negatively regulates antigen receptor-mediated signals in thymocytes, lymph node T cells and B1a cells. CD5 contains four tyrosine residues in its cytoplasmic domain and is phosphorylated on tyrosine residues following antigen receptor ligation. Recently it has been proposed that CD5 function is dependent on the recruitment of the tyrosine phosphatase SHP-1 to tyrosine-phosphorylated CD5 and subsequent dephosphorylation of signaling molecules. In this study we investigated the requirements for, and sites of, CD5 tyrosine phosphorylation. Using a T cell line deficient in the tyrosine kinase p56 lck and the same cell line reconstituted with this kinase, we show that p56 lck expression is required for efficient CD5 tyrosine phosphorylation. Using tyrosine-phosphorylated peptides corresponding to CD5 cytoplasmic sequences we also show that the Src homology 2 (SH2) domain of p56 lck binds prominently to pY429SQP, with 30-fold less affinity to pY463DLQ and not to pY441PAL. A number of murine CD5 Y → F and deletion mutants were expressed in Jurkat T cells. The Y441F mutant was tyrosine phosphorylated at levels comparable to wild-type, but the Y429F and Y463F mutants were phosphorylated at lower levels. Two deletion mutants, which contain only one tyrosine residue (Y378) located at the interface of the transmembrane and cytoplasmic domains, were not tyrosine phosphorylated, suggesting that Y378 is not readily available for phosphorylation. Taken together these results suggest that both Y429 and Y463 can recruit p56 lck , and that these residues are the only prominent sites for CD5 tyrosine phosphorylation.
Introduction
The destructive potential of the immune system necessitates ment of purified peripheral T cells with solid-phase-bound anti-CD3 antibody together with anti-CD5 antibody led to tight control of cellular effector functions by means of positive and negative regulatory receptors. One such receptor is the the production of IL-2 and proliferation (2). However, subsequent studies of CD5-deficient mice indicated that TCRglycoprotein CD5, which is expressed on thymocytes, T cells and a B cell subset. Initial experiments using antibodymediated proliferative responses were enhanced in thymocytes, suggesting a negative regulatory function for CD5 (6) . mediated cross-linking of surface receptors suggested that CD5 enhances TCR-CD3-mediated responses (1-5). TreatLymph node T cells and B1a cells from CD5 -/-mice similarly show enhanced antigen receptor-mediated proliferative the cytoplasmic domain of CD5, and eventually to address the functions of the four cytoplasmic tyrosine residues in CD5. responses, again suggesting a negative regulatory function for CD5 in these cells (7, 8) .
CD5 associates with the TCR (9) and BCR (10) , and is Methods phosphorylated on serine, threonine and tyrosine residues
Reagents, vectors and antibodies following TCR stimulation (11, 12) . One of the kinases responsible for phosphorylating CD5 is the tyrosine kinase
The pGEX-2T vector (18) was a gift from Dr A. Cowman p56 lck , which can also bind to tyrosine phosphorylated CD5 (Walter and Eliza Hall Institute, Victoria, Australia). Murine by means of its Src homology 2 (SH2) domain (13) . The anti-human CD5 (UCHT2, IgG1) hybridoma was from Dr P. transmembrane/cytoplasmic domain of CD5 contains four Beverley (University College, London), rat anti-mouse CD5 tyrosine residues, and shows some similarity to both immuno-(YTS 121.5.2, IgG2b) (19) hybridoma was from the ECCC receptor tyrosine-based activation motif (ITAM) and inhibition (Salisbury, UK), murine anti-human CD3 (OKT3, IgG2a) (20) motif (ITIM) sequences ( Fig. 1) (14) (15) (16) . We have previously hybridoma was from the ATCC (Rockville, MD), and murine shown using tyrosine-phosphorylated peptides correspondanti-human C3b inactivator (OX-21, IgG1) (21) hybridoma ing to CD5 cytoplasmic domain sequences that the was from Dr D. Mason (MRC Cellular Immunology Unit, ITAM-like sequence of CD5 binds to the TCR ζ-associated Oxford, UK). mAb against phosphotyrosine (PY20) was from protein ZAP-70 with low affinity and is unlikely to be an ITAM Transduction Laboratories (Lexington, KY) and polyclonal (14) . A number of negative regulatory receptors contain antibody to p59 fyn was from Santa Cruz Biotechnology (Santa ITIM sequences, which once phosphorylated recruit SH2 Cruz, CA). Rabbit antiserum directed against the p56 lck domain-containing phosphatases (17) . Recently CD5 has sequence RNGSEVRDPLVTYEGSNPPA (22) was from Dr J. been proposed to negatively regulate TCR-mediated signaling Borst (The Netherlands Cancer Institute, Amsterdam) and by recruiting the tyrosine phosphatase SHP-1 (15) . Such rabbit antiserum directed against the human CD5 cytoplasmic negative regulatory function was dependent on the phossequence SSMQPDNSSDSDYDLHGAQRL (23) was from Dr phorylation of Y378, which was identified as the site of D. Mason (John Radcliffe Hospital, Oxford, UK). SHP-1 binding to CD5 (15) .
Peroxidase-conjugated goat anti-mouse and goat antiThe aim of this study was to determine the requirements for, rabbit antibodies were from Caltag (San Francisco, CA). and sites of, tyrosine phosphorylation in the CD5 cytoplasmic Glutathione-agarose, streptavidin-agarose, Protein Adomain. To determine how important the tyrosine kinase p56 lck Sepharose and Protein G-Sepharose were from Sigma (St is for tyrosine phosphorylation of CD5, a comparison was Louis, MO), and rabbit anti-mouse Ig, sheep anti-rat Ig, sheep made between a cell line lacking this kinase and the same cell anti-rat-FITC and sheep anti-mouse-FITC were from Serotec line reconstituted with p56 lck . Using tyrosine-phosphorylated (Oxford, UK (Fig. 1) were synthesized by Genosys (Cambridge, 960 µF, infinite resistance). Culture supernatants were removed after 24-48 h, filter sterilized and incubated with Jurkat cells in UK). A tyrosine-phosphorylated peptide corresponding to the optimal binding phosphopeptide for p56 lck SH2 (EPQYEEIPI the presence of 8 µg/ml polybrene for 24 h. After 3-4 days cells were electronically sorted for CD5 expression using a FACS denoted pYEEI) (24) was also synthesized by Genosys. Peptides were immobilized at 0.3-10 nmol on 25 µl packed
Vantage cytometer (Becton Dickinson). Selected cells were expanded, labeled with rat anti-mouse CD5 antibody followed streptavidin-agarose or Affigel-15 (BioRad, Hercules, CA) beads to give a final concentration of 0.3-10 µM peptide in by anti-rat κ chain-magnetic microbeads (Miltenyi Biotec, Bergisch Gladbach, Germany) and magnetically sorted for a 1 ml lysate/solution used for each precipitation.
second time.
Synthesis of p56 lck SH2 fusion protein construct and preparation of fusion protein Cell stimulation, lysis and affinity precipitation of protein
Cells were washed with HBSS, pH 7.3, and 100 µl aliquots RNA was prepared from phytohemagglutinin (PHA)-stimulated T blasts. cDNA was made using the Amersham containing 2ϫ10 7 Jurkat cells were used per sample. Cells were preheated to 37°C for 1 min and stimulated by the cDNA synthesis PLUS kit and PCR was performed with oligonucleotides, containing flanking EcoRI and BamHI sites, addition of 5 µl Na-pervanadate (final concentration 3 mM H 2 O 2 , 0.1 mM Na-vanadate), a tyrosine kinase activator designed to generate the SH2 domain of p56 lck (amino acids 118-235). Products were run on 2% agarose gels, correctly and phosphatase inhibitor (32, 33) , followed by incubation at 37°C for 1-5 min. For studies involving receptor cross-linking, sized fragments were retrieved from the agarose and ligated into the pGEX-2T vector, cut with EcoRI and BamHI, for cells were treated with 10 µg mAb premixed with 2 µg antiIg secondary antibody for 2 min at 37°C (12) . Cells were generation of glutathione S-transferase fusion products. The sequence of the insert was verified, and fusion protein was lysed by the addition of 1 ml 1.1ϫNP-40 or Brij-96 lysis buffer (final concentration 1% NP-40 or Brij-96, 10 mM Trisexpressed in Escherichia coli MC1061 cells and purified by affinity chromatography using glutathione-agarose (18) .
HCl, pH 8.0, 150 mM NaCl, 1 mM Na-vanadate, 1 mM EDTA, 1 mM PMSF and 5 mM iodoacetamide) and incubated on ice Protein concentrations were estimated using the Bradford assay as modified by Read and Northcote (25) .
for 20-30 min. Nuclei were pelleted at 14,000 g for 10 min at 4°C. Supernatants were added to 25 µl glutathione-agarose Generation and expression of mutant CD5 in Jurkat cells prebound to 5 µg fusion protein, or to 25 µl Protein A-or Protein G-Sepharose beads prebound to 2-5 µg antibody. Mismatch primer mutagenesis (26) was used to produce mutations within murine CD5 cDNA. A 3Ј fragment of CD5 Precipitations using synthetic peptides were performed using 0.3-10 nmol (µM) peptide coupled to 25 µl Affigel-15 (BioRad, cDNA (nucleotides 525-1657), containing the region coding for the intracellular domain, was excised from the plasmid Hercules, CA) or streptavidin-agarose beads. Cell lysates were incubated with the beads for 1.5-2 h at 4°C. pCD CD5 (27) using the unique EcoRI and ApaI restriction sites. The fragment was ligated, using a DNA linker containWestern blotting ing flanking regions complimentary to ApaI and KpnI restriction sites, into RF M13 mp18 (28) . Single-stranded, For detection of proteins by Western blotting, beads were washed 4 times with NP-40 lysis buffer. Bound proteins uracil-containing phage DNA was extracted from infected E. coli CJ236 (dut -ung -) cells, and mutagenesis and selection were denatured by boiling for 5 min in 50 µl reducing sample buffer. Aliquots (20 µl) were subjected to SDS-10% PAGE (34) performed as described by Kunkel et al. (26) .
The 5Ј coding region of CD5 (nucleotides 1-524) was and proteins were transferred to Hybond-C extra (Amersham, Little Chalfont, UK) membranes for 1 h at 100 V. Proteins were excised from pCD CD5 using the unique NcoI and EcoRI restriction sites. The fragment was ligated, using linker DNAprobed with primary antibody in TBS-Tween (10 mM TrisHCl, pH 7.4, 140 mM NaCl and 0.1% Tween 20) for 1 h containing flanking regions complimentary to NcoI and SalI restriction sites, into RF M13 mp18 and then excised using at room temperature, followed by peroxidase-conjugated efficiently, following cross-linking of CD3 in lck ϩ cells. Given such poor induction of CD5 tyrosine phosphorylation in JCaM1/lck cells, a comparison of CD5 tyrosine phosphorylation was not made following cross-linking of CD3 in lck ϩ and lck -cells.
Sites of tyrosine phosphorylation in the CD5 cytoplasmic domain
To determine the importance of each tyrosine residue in CD5 tyrosine phosphorylation, Y → F as well as deletion mutants of murine CD5 were generated. There are four tyrosine residues in the CD5 transmembrane/cytoplasmic domain. Y378 occurs at the junction of the transmembrane and cytoplasmic domains, N-terminal to three lysine doublet anchoring sequences (Fig. 3) . To remove as much of the cytoplasmic domain as possible without interfering with the anchoring of CD5 in the membrane, the deletion mutant 389∆ was constructed. The deletion mutant 429∆ was also constructed to remove the C-terminal three tyrosine residues. Each of these tyrosine residues was mutated to phenylalanine to generate Y429F, Y441F and Y463F CD5 point mutants.
Murine wild-type CD5, and 389∆, 429∆, Y429F, Y441F and Y463F CD5 mutants were expressed in the human CD5 -, CD3 ϩ T cell line Jurkat 1.15 M46 (3). Assessed by flow cytofluorometric analysis, levels of CD5 expression were all CD5 constructs (Fig. 4A) . induced the comparable tyrosine phosphorylation of wildtype and Y441F CD5, and a lower level of Y429F CD5 tyrosine phosphorylation (Fig. 4A ). There were very low levels of Y463F CD5 tyrosine phosphorylation, whereas the deletion mutants secondary antibody for 1 h at room temperature and detection 389∆ and 429∆ were not tyrosine phosphorylated following using ECL substrate (Amersham).
pervanadate stimulation (Fig. 4A) . Differential tyrosine phosphorylation of CD5 mutants was also induced following cross-linking of CD3 (Fig. 4B) .
Results
There were low levels of constitutive tyrosine phosphorylation Requirement of p56 lck expression for efficient CD5 tyrosine of wild-type and Y441F CD5, and tyrosine phosphorylation of phosphorylation in Jurkat T cells these proteins was enhanced following cross-linking of CD3. By contrast, Y429F and Y463F CD5 were not constitutively Using co-transfection experiments in COS cells Raab et al. (13) showed that CD5 is a substrate for the tyrosine kinase tyrosine phosphorylated, but a low level of Y429F CD5 tyrosine phosphorylation could be induced following cross-linking of p56 lck . In order to complement this study, the p56 lckdeficient (JCaM1) cell line and the same cell line reconstituted CD3 (Fig. 4B) . The deletion mutants 389∆ and 429∆ were not tyrosine phosphorylated following cross-linking of CD3 (results with p56 lck (JCaM1/lck) (35) were used to determine the importance of p56 lck expression for CD5 tyrosine phosphorylanot shown). tion in Jurkat T cells.
Association of the p56 lck SH2 domain with CD5 cytoplasmic CD5 is phosphorylated on tyrosine, serine and threonine domain phosphopeptides and CD5 mutants residues in vivo (11, 36) and in vitro (9, 12, 37) . To detect CD5 tyrosine phosphorylation, Western blotting was used following Three tyrosine-phosphorylated peptides corresponding to CD5 cytoplasmic sequences (Fig. 1) were used to determine cell lysis in NP-40 lysis buffer (Fig. 2) . Pervanadate, a nonspecific tyrosine kinase activator and phosphatase inhibitor the potential sites at which p56 lck interacts with CD5. Although cellular p56 lck could not be detected in CD5 phosphopeptide (32, 33) , was used to induce maximal tyrosine phosphorylation of CD5. There was no detectable CD5 tyrosine phosphorylaprecipitates (14) , the recombinantly expressed SH2 domain of p56 lck bound strongly to pY429SQP, with~30-fold lower tion in unstimulated or pervanadate-stimulated lck -cells. However, in unstimulated lck ϩ cells there was a low level affinity to pY463DLQ and not to pY441PAL (Fig. 5A) . The binding of the p56 lck SH2 domain to CD5 thus appears to be of constitutive CD5 tyrosine phosphorylation and this was increased following pervanadate stimulation (Fig. 2) . Tyrosine mediated predominantly by the pY429SQP sequence with a possible minor contribution by the pY463DLQ sequence. phosphorylation of CD5 could also be induced, although not In order to confirm the sites of p56 lck association with CD5, equal loading of precipitating p56 lck SH2 domain (result not shown), following which the membrane was blocked and the recombinant SH2 domain of p56 lck was used to precipitate CD5 Y → F point mutants from pervanadate-stimulated Jurkat probed with a polyclonal antibody to CD5. wild-type and Y441F CD5 bound equally well to the p56 lck SH2 domain. 1.15 M46 cells. Immediately after protein transfer the nitrocellulose membrane was stained with Ponceau S to ensure However, neither Y429F nor Y463F CD5 mutants were precipitated by the p56 lck SH2 domain (Fig. 5B) , despite the recombinant fusion proteins or a number of signal transducing proteins in thymocyte lysates (39 and results not shown). clearly detectable tyrosine phosphorylation of the Y429F Neither of the 389∆ or 429∆ CD5 deletion mutants were mutant (Fig. 4A) .
tyrosine phosphorylated following pervanadate stimulation or cross-linking of CD3 (Fig. 4A , result not shown). Since both deletion mutants contain only one tyrosine residue (Y378), Discussion which potentially could lie in the cytoplasmic domain, this The previous demonstration that CD5 is tyrosine phosresidue is unlikely to be a site for CD5 tyrosine phosphorylaphorylated by p56 lck used co-transfection experiments in COS tion. These results differ from those of Perez-Villar et al. (15) . cells (13) . Using p56 lck -deficient and reconstituted cell lines These authors generated chimeric molecules encoding the we show here that CD5 is tyrosine phosphorylated in lck ϩ extracellular domain of murine CD6 and the intracellular cells but not in lck -cells following pervanadate stimulation
domain of human CD5 to analyze the function of CD5. In (Fig. 2) . Although both lck -and lck ϩ cells express the tyrosine direct contrast to the results presented in the present study, the kinase p59 fyn , as detected by Western blotting and in vitro 429∆ mutant CD5-CD6 chimera was shown by Perez-Villar kinase assays (results not shown and 38), the levels of tyrosine et al. (15) to be tyrosine phosphorylated, suggesting that phosphorylation in whole-cell lysates from lck -cells induced Y378 lies within the CD5 cytoplasmic domain and is available after pervanadate stimulation or cross-linking of CD3 were for phosphorylation. The reason for the differences between Ͻ10-fold lower than that from lck ϩ cells (results not shown).
the study of Perez-Villar et al. (15) and the present study is Even though such low levels of tyrosine phosphorylation occur not clear. One possibility is that the architecture of the in lck -cells, the results presented here do not necessarily chimeric transmembrane domains, and therefore the localizaexclude a role for p59 fyn in CD5 tyrosine phosphorylation.
tion of Y378, differs from that of native murine CD5. Secondly, Nevertheless, these results complement the study by Raab Perez-Villar et al. expressed the chimeras in CD5 ϩ as opposed et al. (13) in demonstrating that p56 lck , and potentially other to CD5 -Jurkat cells. It is possible that the tyrosine phoskinases whose activity depends on p56 lck , plays a prominent phorylation of the 429∆ CD5-CD6 chimera is due to transrole in CD5 tyrosine phosphorylation.
phosphorylation by p56 lck associated with full-length CD5 in The comparable tyrosine phosphorylation of wild-type and the cells used by Perez-Villar et al. (15) . To address this Y441F CD5 following pervanadate stimulation or cross-linking possibility, we expressed the panel of murine CD5 mutants of CD3 (Fig. 4) indicates that Y441 is not phosphorylated or in the human CD5 ϩ cell line Jurkat J5. Again the 429∆ mutant phosphorylated at low stoichiometry. Additionally, the was not tyrosine phosphorylated following pervanadate comparable binding of the p56 lck SH2 domain to tyrosinestimulation or co-cross-linking of CD3 with murine and human phosphorylated wild-type and Y441F CD5 (Fig. 5B ) and lack CD5, despite the tyrosine phosphorylation of Y429F and of binding of this domain to the pY441PAL peptide (Fig. 5A) Y441F mutants as well as low levels of Y463F tyrosine suggest that the Y441 sequence is not a binding site for phosphorylation (result not shown). Taken together, the p56 lck . The functional significance of Y441 remains unresolved location of Y378 N-terminal to three lysine doublets suggests that this residue is at the interface of the transmembrane and since the pY441PAL peptide did not bind to a panel of cytoplasmic domains, and the lack of phosphorylation of Y378
Previous observations by Perez-Villar et al. (15) indicated a necessary role for Y378 in the interaction between CD5 and in this study suggests that it is not readily available for phosphorylation.
SHP-1 in Jurkat T cells. We have been unable to detect phosphorylation of Y378, suggesting that if phosphorylation The diminished tyrosine phosphorylation of Y429F and Y463F CD5 mutants (Fig. 4) indicates that these residues are of this residue is important for SHP-1 interaction, the association is unlikely to occur at high stoichiometry. Clearly more the two prominent sites for CD5 tyrosine phosphorylation. Given that the residues N-terminal to Y429 are identical to extensive mutagenesis studies are required to clarify the role of CD5 tyrosine phosphorylation as well as the tyrosine those in the autophosphorylation site of Src-like kinases (Fig. 1) (9) , this sequence was predicted to be the most phosphatase SHP-1 in the negative regulatory function of CD5. Jurkat 1.15 M46 cells were chosen to express CD5 and prominent site for CD5 tyrosine phosphorylation. However, contrary to expectation, the Y463F mutant is phosphorylated CD5 mutants because these cells produce IL-2 following stimulation through the TCR-CD3 complex (3). Although at lower levels than the Y429F mutant. The inability of the p56 lck SH2 domain to precipitate the tyrosine-phosphorylated Jurkat 1.15 M46 CD5 infectants did produce detectable levels of IL-2 in isolated experiments, these results were not Y429F mutant (Fig. 5B) , together with the prominent binding of this domain to the pY429SQP peptide (Fig. 5A) , suggest reproducible (results not shown). The panel of CD5 mutants will be expressed in other cell lines in order to compare IL-2 that Y429 is the major site for p56 lck recruitment. However, the fact that the Y429F mutant is tyrosine phosphorylated secretion following stimulation through the TCR-CD3 complex as well as following co-cross-linking of TCR-CD3 and CD5. indicates that p56 lck can be recruited in the absence of Y429 phosphorylation. The weak binding of the p56 lck SH2 domain
In this study the Y378F CD5 mutant was not produced because of the location of Y378 N-terminal to three lysine to the pY463DLQ peptide suggests that Y463 can recruit p56 lck . Although we cannot explain the lack of prominent doublet sequences and hence the likely location of this residue in the transmembrane region. In light of the results of Y463F mutant tyrosine phosphorylation, such weak phosphorylation may imply that Y463 is phosphorylated at greater Perez-Villar et al. (15) that Y378 is necessary for the inhibitory function of CD5, it will be necessary to compare cellular stoichiometry than Y429 or that phosphorylation of Y463 is required for subsequent phosphorylation of Y429. The latter effector functions of the Y378F mutant in murine CD5 with other CD5 mutants used in this study. Such experiments are possibility would account for the inability of the p56 lck SH2 domain to precipitate the Y463F CD5 mutant from currently underway and will form the basis of a further communication. pervanadate-stimulated cells (Fig. 5B) as a consequence of the weak tyrosine phosphorylation of this mutant (Fig. 4A) . Taken together, these results suggest that both the Y429 and Acknowledgements Y463 sequences can recruit p56 lck , and that these residues This paper is dedicated to the memory of Albert Beyers who died are the only prominent sites for CD5 tyrosine phosphorylation. study, we were able to detect the p85 subunit of phosphatidylinositol 3-kinase associated with wild-type CD5 Abbreviations and the Y441F CD5 mutant, but not with either Y429F CD5 or Y463F CD5 mutants (result not shown). We were not able 
